ANIMATION

Vasopressin V2-Receptor Blockage

Share this article with:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

XVIVO has produced several high quality animation videos for us and we will keep going back to them with future projects. This company provides exceptional customer service and has been a pleasure to work with.

Sr. Manager, New Products Marketing, Kinetic Concepts, Inc. (KCI)